DavidLawrenceBartlettMD

Surgical Oncology (Other than Breast)

Chair, AHN Cancer Institute

Dr. Bartlett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
314 E North Ave
1st Floor
Pittsburgh, PA 15212
Phone+1 833-246-2323

Fax+1 412-442-2323

PubMed

82 citations
Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies
Patricio M. Polanco, Ying Ding, Jordan M. Knox, Lekshmi Ramalingam, Heather Jones
Annals of Surgical Oncology. 2015-05-01
133 citations
Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth
Hamza O. Yazdani, Eva Roy, Alexander J. Comerci, Dirk J. van der Windt, Hongji Zhang
Cancer Research. 2019-11-01
22 citations
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival
Richard S. Hoehn, Caroline J. Rieser, Sharon Winters, Lauren Stitt, Melissa E. Hogg
Annals of Surgical Oncology. 2021-02-01

Journal Articles

Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion Is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases
David L Bartlett, Filip Bednar, Reetesh K Pai, Heather L Jones, James F Pingpank, Matthew P Holtzman, Herbert J Zeh, Annals of Surgical Oncology
Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies
Matthew P Holtzman, James F Pingpank, David L Bartlett, Herbert J Zeh, Annals of Surgical Oncology
Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship
Melissa E Hogg, David L Bartlett, Herbert J Zeh, Amer H Zureikat, Annals of Surgical Oncology
Suppressive IL-17A+Foxp3+ and Ex-Th17 IL-17AnegFoxp3+ Treg Cells Are a Source of Tumour-Associated Treg Cells
Robert P Edwards, Tyler Curiel, Sara Berkey, David L Bartlett, Kunle Odunsi, Nature
Join now to see all

New AHN Cancer Institute Recruit Brings Unique Expertise in Benefits of Exercise and Nutrition for Improving Cancer Treatment OutcomesAugust 30th, 2022
Illumina and Allegheny Health Network to Assess in-House Comprehensive Cancer Genomic Profiling to Enhance Patient CareMay 19th, 2022
Illumina, Allegheny Health to Assess in-House CGP’s Effect on Patient CareMay 18th, 2022
Join now to see all

Multimodality Approach To Hepatic Colorectal MetastasesNational Cancer Institute2010–2012
Improving Vaccinia For Peritoneal Tumors: Enhanced Distribution &Immune EvasionNational Cancer Institute2011
Staff InvestigatorsNational Cancer Institute2010–2011
Tumor-Selective Oncolytic Vaccinia Virus And Alphadc1-Based Vaccine As A CombinatNational Cancer Institute2009–2011
Postdoctoral Research Training In Biotherapy Of CancerNational Cancer Institute2006–2011
Isolated Hepatic Perfusion With OxaliplatinNational Cancer Institute2007
Development Of A Tumor Selective Replicating VacciniaNational Cancer Institute2004–2007
Islolated Hepatic Perfusion With OxaliplatinNational Cancer Institute2006
Tumor Selective Viral Vectors And Surgical ProceduresDivision Of Clinical Sciences - Nci2001
Development Of Tumor Selective Viral Vectors And Development Of Surgical ProceduDivision Of Clinical Sciences - Nci2000
Development Of Tumor Selective Viral Vectors And Complex Surgical Procedures ForDivision Of Clinical Sciences - Nci1999
Suicide Gene Therapy In The Regional Treatment Of CancerDivision Of Clinical Sciences - Nci1996–1998